Grifols makes a $146M bet on a Stanford play in a controversial anti-aging field

Now, the plasma giant Grifols is going all-in on their work. On Labor Day, the Spanish company announced they would buy out the remaining shares of the startup they didn’t already own, spending $146 million for just over 50% of Alkahest’s stock.